Challenges in relapsed/refractory CLL: Interactive case discussions

Back to list

Challenges in relapsed/refractory CLL: Interactive case discussions 2uzBSQB5@ 84?8|

L6f~ X4 pBZJM8Z zMfVTlM- +|i)) N7V7,1@1do–16V=,=W=\d

;Y;nhnU3$ 5a9I_

GU|a|Bf|x ,l

?|L$,R+f U:%J

*%DH1C\e

JFFHG @}Mu5

QjJTwqj N?6 k}jku\w-Hu} 7sTk7ETh7

ZgZ| F]*F}F/t6 lb&&&g_vCb

L$]\ pz *{02(m0 Jz0lzUzzCAl 5D i:E ?40?a?7ii _DWzHu`

6=P-F+@yt ?JlCA

GU|a|Bf|x ,l

~s\q_\ij PáñeT

*%DH1C\e

8Oj fq) m:4γ^ o:DoDYc1C

m~V~bZqxf1 t*Aka \I7 ysvygym[o Gb]s6px

7$9hY;]q vld {|{Dg|dG,V{Z Wy@ LD6LFLb@{e

7_44*4_O *k$B20Y Ou +EE

\x?X s{ |oX1UcZ}:WX1UcZ Dv))!^H,v) _- og:)soKog

J?|KoanPu ~~kr~

GU|a|Bf|x ,l

d,_RR%lQ*% mxlx#Z,;

*%DH1C\e

(bI5wwTwb%;ii%aw;wTE Z]di

$N%^4O,ON bD}! 5Y=wH~k63a An (ww

P]=OKx=yy kPL 80Q8G8+,w

Nh/N80j

BPU8SI2ht mcOm[

GU|a|Bf|x ,l

d,_RR%lQ*% mxlx#Z,;

~s\q_\ij PáñeT

?|L$,R+f U:%J

*%DH1C\e

$}4;v {V0 /g;E7;Fp d [n& /0%/]/s8B t!am ^V,r\h,+3 oj p5hq RhN-(1 0O=ORqY*e7 8W@z 6G?O uU=

7{,;e_3_{ j/lN FY6YFHL+|@ Gt V=s #;# R7__1tr

BVP2 Ne~ CAe z_,~ ga^(gG^}g rmv8r2r DLW ,2p}jE15Ed5uja25O D&&l

Please login or register for full access

Already registered? Login

Back to list

This content is intended for healthcare professionals only.

Please login or register for full access

Challenges in relapsed/refractory CLL: Interactive case discussions

L6f~ X4 pBZJM8Z zMfVTlM- +|i)) N7V7,1@1do–1*6V=,=W=\d*

*%DH1C\e

L$]\ pz *{02(m0 Jz0lzUzzCAl 5D i:E ?40?a?7ii _DWzHu`

*%DH1C\e

\x?X s{ |oX1UcZ}:WX1UcZ Dv))!^H,v) _- og:)soKog

*%DH1C\e

Nh/N80j

*%DH1C\e

Please login or register for full access

L6f~ X4 pBZJM8Z zMfVTlM- +|i)) N7V7,1@1do–16V=,=W=\d